“Evaluating the Clinical Efficacy and Safety of Subcutaneous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review”. The Medical Journal of General Medicine 1, no. 1 (October 7, 2024): 1–16. Accessed November 4, 2026. https://medicaljournalinternational.org/tmjgm/article/view/1.